Market revenue in 2022 | USD 13,124.6 million |
Market revenue in 2030 | USD 24,054.9 million |
Growth rate | 7.9% (CAGR from 2022 to 2030) |
Largest segment | Artificial organ |
Fastest growing segment | Artificial bionics |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Artificial Organ, Artificial bionics |
Key market players worldwide | Zimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial organs and bionics market will help companies and investors design strategic landscapes.
Artificial organ was the largest segment with a revenue share of 70.26% in 2022. Horizon Databook has segmented the U.S. artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the U.S. dominated the market owing to a large patient pool, favorable reimbursement policies, and an increase in the number of organ transplantation procedures. A large number of people on the waiting list, coupled with technological advancements in the field of artificial organs, is expected to drive the market.
The number of organ donors in the U.S. has increased significantly over the past decade. According to the U.S. Department of Health & Human Services, there was a 40% increase in the number of organ donors from 2011 to 2019. Growing demand for kidney transplantation is one of the major market drivers.
Kidney transplantation witnessed exponential growth, from 16,186 transplants in 2011 to 23,401 transplants in 2019. An increase in the aging population is also boosting the need for artificial organs. The number of organ transplants in individuals older than 65 years in 2020 is almost double as compared to 2011.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. artificial organs and bionics market, including forecasts for subscribers. This country databook contains high-level insights into U.S. artificial organs and bionics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account